ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 294

$815K Total Retail Price of All Prescriptions

Rank: 3 out of 294

303 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 303 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

14% of this provider’s 303 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

0% of this provider’s 5,301 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$124 was the average price of a prescription from this provider, compared to $84 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
CARVEDILOL 193 168 1 8
AMLODIPINE BESYLATE 184 160 2 3
SIMVASTATIN 156 134 3 7
PRAVASTATIN SODIUM 155 116 4 11
METOPROLOL TARTRATE 147 125 5 6
LISINOPRIL 132 93 6 2
METFORMIN HCL 117 94 7 30
CLOPIDOGREL 110 83 8 10
ATORVASTATIN CALCIUM 109 96 9 4
HYDROCODONE-ACETAMINOPHEN 102 61 S3 10 75
FUROSEMIDE 98 82 11 5
PLAVIX 95 85 12 14
METOPROLOL SUCCINATE 94 63 13 1
TRAMADOL HCL 90 66 14 61
DIOVAN 87 73 15 24
DONEPEZIL HCL 83 80 16 46
LEVOTHYROXINE SODIUM 83 82 16 25
TAMSULOSIN HCL 80 79 18 45
FLUOXETINE HCL 78 48 19 107
GABAPENTIN 78 52 19 81
RANEXA 76 64 21 38
AMLODIPINE BESYLATE-BENAZEPRIL 73 71 22 32
ALENDRONATE SODIUM 72 62 23 57
GLIMEPIRIDE 72 61 23 60
ALLOPURINOL 70 64 25 58
AMOX TR-POTASSIUM CLAVULANATE 69 61 26 119
FAMOTIDINE 67 58 27 121
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 62 27 41
CRESTOR 66 44 29 13
JANUMET 61 48 30 130
TORSEMIDE 61 55 30 74
WARFARIN SODIUM 58 49 32 9
LOSARTAN POTASSIUM 57 51 33 15
PANTOPRAZOLE SODIUM 57 56 33 50
LOSARTAN-HYDROCHLOROTHIAZIDE 55 50 35 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.